High Production of Glycosylated Human Interferon Alpha2b in HEK293 Cells
Author Information
Author(s): Martin Loignon, Sylvie Perret, John Kelly, Denise Boulais, Brian Cass, Louis Bisson, Fatemeh Afkhamizarreh, Yves Durocher
Primary Institution: National Research Council Canada
Hypothesis
Can HEK293 cells be engineered for high-level production of glycosylated human recombinant IFNα2b?
Conclusion
The HEK293 cell line is an efficient host for producing biologically active and glycosylated human IFNα2b.
Supporting Evidence
- HEK293 cells produced over 200 mg of IFNα2b per liter of culture.
- The purification method yielded 98% pure IFNα2b with over 70% recovery.
- Purified IFNα2b was shown to be biologically active in antiviral assays.
Takeaway
Scientists made a special version of a human protein in cells that can help fight viruses, and they found a way to make a lot of it quickly and easily.
Methodology
HEK293 cells were engineered to produce IFNα2b, which was purified using cation-exchange chromatography.
Limitations
The study does not address potential scalability issues for industrial production.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website